RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q2 EPS of ($0.71), $0.01 better than the analyst estimate of ($0.72).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.